Cellular immunological effects of laser irradiation and immunoadjuvant application

Wei R. Chen; Abdiwahab Mohamed; Mark F. Naylor; Kenneth E. Bartels; Jerry W. Ritchey; Hong Liu; Robert E. Nordquist

doi:10.1117/12.698012

13 February 2007 Cellular immunological effects of laser irradiation and immunoadjuvant application

Wei R. Chen, Abdiwahab Mohamed, Mark F. Naylor, Kenneth E. Bartels, Jerry W. Ritchey, Hong Liu, Robert E. Nordquist

Proceedings Volume 6438, Biophotonics and Immune Responses II; 64380B (2007) https://doi.org/10.1117/12.698012
Event: SPIE BiOS, 2007, San Jose, California, United States

Abstract

Immune system is critical in the fight against cancer. Particular important is the responses through immune cells that regulate immunological functions. Certain cytokines enhance cancer immunity (such as IL12 and interferon gamma) and others interfere or impede cancer immunity (such as IL10). The clinical outcome can be linked to the balance of these cytokines, such as IL10 to IL12 ratio. Effective treatments often reduce the IL10:IL12 ratio, indicating higher levels of the cancer fighting IL12. To enhance immune responses, a combination of laser irradiation and concurrent use of immunostimulants has been applied for the treatment of tumors. In a recent study, an 805-nm laser in conjunction with indocyanine green (ICG) has been used to treat EMT6 mammary tumors in mice. An immunoadjuvant, glycated chitosan (GC), was intratumoral injected after the laser irradiation. Our preliminary results showed that tumor-bearing mice treated either with the immunoadjuvant alone or with the combination of laser and immunoadjuvant had lower IL10:IL12 ratios than animals that received no treatment. This may play an important in the treatment to decrease tumor size and to increase survival times of mice. Cellular activities after laser-ICG-GC treatment of DBMA-4 mammary tumors in rats also showed infiltration of immune cells to the treatment sites, indicating a possible induced immunity. The combination of laser treatment and immunotherapy has been used to treat late-stage melanoma patients; the responses, both treated primary tumors and the metastases, to the treatment have been promising. The histology of two patients, before and after treatment, is presented to show the effects of this novel treatment method.

Citation Download Citation

Wei R. Chen, Abdiwahab Mohamed, Mark F. Naylor, Kenneth E. Bartels, Jerry W. Ritchey, Hong Liu, and Robert E. Nordquist "Cellular immunological effects of laser irradiation and immunoadjuvant application", Proc. SPIE 6438, Biophotonics and Immune Responses II, 64380B (13 February 2007); https://doi.org/10.1117/12.698012

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available